ACCOUNTING POLICIES (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Product Information [Line Items] | |||
| Deposits assets | $ 4,257,000 | ||
| Inventory write-off | 0 | $ 0 | |
| Valuation allowance, deferred tax asset, change in amount | $ 1,074,000 | ||
| Valuation allowance | $ 10,326,000 | $ 10,326,000 | |
| Antidilutive securities excluded from computation of earnings per share, amount | 112,000 | 7,000 | |
| Weighted average exercise price | $ 12.79 | $ 17.51 | |
| Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member] | |||
| Product Information [Line Items] | |||
| Concentration risk percentage | 10.00% | ||
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member] | |||
| Product Information [Line Items] | |||
| Concentration risk percentage | 28.00% | 42.00% | |
| X | ||||||||||
- Definition Antidilutive securities excluded from computation of earnings per share weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|